Cartesian Therapeutics, Inc. Class of Warrant or Right, Outstanding
Cartesian Therapeutics, Inc. (RNAC) had Class of Warrant or Right, Outstanding of 692.27 thousand shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-08-06
- 2026-06-30: Class of Warrant or Right, Outstanding 692.27K shares.
- 2026-03-31: Class of Warrant or Right, Outstanding 692.27K shares.
- 2025-12-31: Class of Warrant or Right, Outstanding 692.27K shares.
- 2025-09-30: Class of Warrant or Right, Outstanding 692.52K shares.
| Period end | Class of Warrant or Right, Outstanding | Class of Warrant or Right, Outstanding as first filed |
|---|---|---|
| 2026-06-30 | 692.27K shares 10-Q · filed 2026-08-06 | |
| 2026-03-31 | 692.27K shares 10-Q · filed 2026-04-30 | |
| 2025-12-31 | 692.27K shares 10-K · filed 2026-03-09 | |
| 2025-09-30 | 692.52K shares 10-Q · filed 2025-11-06 | |
| 2025-06-30 | 692.52K shares 10-Q · filed 2025-08-07 | |
| 2025-03-31 | 692.52K shares 10-Q · filed 2025-05-08 | |
| 2024-12-31 | 692.52K shares 10-K · filed 2026-03-09 | |
| 2024-09-30 | 974.95K shares 10-Q · filed 2024-11-07 | |
| 2024-06-30 | 975.13K shares 10-Q · filed 2024-08-08 | |
| 2024-03-31 | 975.13K shares 10-Q · filed 2024-05-08 | |
| 2023-12-31 | 1.04M shares 10-K · filed 2026-03-09 | 31.22M shares 10-K · filed 2024-03-07 |
| 2023-09-30 | 31.22M shares 10-Q · filed 2023-11-13 | |
| 2023-06-30 | 31.23M shares 10-Q · filed 2023-08-17 | |
| 2023-03-31 | 31.23M shares 10-Q · filed 2023-05-04 | |
| 2022-12-31 | 1.04M shares 10-K · filed 2025-03-13 | 31.23M shares 10-K · filed 2023-03-02 |
| 2022-09-30 | 31.23M shares 10-Q · filed 2022-11-03 | |
| 2022-06-30 | 31.23M shares 10-Q · filed 2022-08-08 | |
| 2022-03-31 | 10.74M shares 10-Q · filed 2022-05-05 | |
| 2021-12-31 | 10.74M shares 10-K · filed 2024-03-07 | |
| 2021-09-30 | 12.38M shares 10-Q · filed 2021-11-09 | |
| 2021-06-30 | 12.38M shares 10-Q · filed 2021-08-12 | |
| 2021-03-31 | 12.38B shares 10-Q · filed 2021-05-13 | |
| 2020-12-31 | 12.38M shares 10-K · filed 2023-03-02 | 12.38B shares 10-K · filed 2021-03-12 |
| 2020-09-30 | 13.89B shares 10-Q · filed 2020-11-05 | |
| 2020-06-30 | 14.84B shares 10-Q · filed 2020-08-06 | |
| 2020-03-31 | 31.43B shares 10-Q · filed 2020-05-07 | |
| 2019-12-31 | 31.43M shares 10-K · filed 2022-03-10 | 31.43B shares 10-K · filed 2020-03-12 |
| 2018-12-31 | 95.62M shares 10-K · filed 2020-03-12 | |
| 2017-12-31 | 176.43M shares 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |